Physician

Marina Kuperman-Beade, M.D., F.A.A.D.

According to 2025 Medicare claims, Marina Kuperman-Beade, M.D., F.A.A.D. (NPI: 1477572816) practices dermatology in the Providence-Warwick, RI-MA market, with the plurality of this provider's patient population coming from Providence, RI. This provider's primary affiliated billing organization is SURGICAL & COSMETIC DERMATOLOGY OF RHODE ISLAND, LLC (NPI: 1770770547; TIN: 201323817) and primary practice location at 02904-2709. Kuperman-Beade is affiliated with the Southcoast Accountable Care Organization, LLC (ACO ID: A1522), participating under the MSSP model.

Kuperman-Beade's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 517 traditional Medicare patients, billed 2,373 HCPCS/CPT codes, and received $494,287 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 1,344 prescription claims across 731 beneficiaries totaling $8,822 in drug costs, led by Mupirocin (Mupirocin). Open Payments data shows 8 records totaling $177. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have declined steadily, from $17,252 to $8,822. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	496	2,384	$524,951
2016	656	2,811	$607,996
2017	639	2,795	$620,910
2018	683	4,857	$847,673
2019	708	4,738	$854,905
2020	553	2,165	$508,401
2021	599	2,630	$617,515
2022	624	2,687	$624,783
2023	586	2,546	$523,642
2024	517	2,373	$494,287

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	420	871	$17,252
2016	559	1,026	$19,390
2017	628	1,114	$15,542
2018	648	1,192	$14,515
2019	669	1,188	$11,750
2020	575	1,141	$21,316
2021	667	1,310	$13,342
2022	734	1,341	$11,990
2023	693	1,267	$8,773
2024	731	1,344	$8,822

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	338	420	$551
17312	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks	108	142	$356
13132	Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm	147	157	$204
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	200	200	$91
99211	Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional	141	289	$20

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mupirocin	Mupirocin	984	18,177	$6,233
Cephalexin	Cephalexin	208	1,441	$746
Ciprofloxacin Hcl	Ciprofloxacin Hcl	62	430	$274
Amoxicillin	Amoxicillin	34	94	$40

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$177	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Marina Kuperman-Beade, M.D., F.A.A.D.?

Tedicare shows public-source Medicare data for Marina Kuperman-Beade, M.D., F.A.A.D. (NPI 1477572816), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marina Kuperman-Beade, M.D., F.A.A.D. have ACO affiliation data?

Marina Kuperman-Beade, M.D., F.A.A.D. is shown with ACO affiliation data for Southcoast Accountable Care Organization, LLC (MSSP, ACO ID A1522).

What billing organization is linked to Marina Kuperman-Beade, M.D., F.A.A.D.?

Marina Kuperman-Beade, M.D., F.A.A.D. is linked to SURGICAL & COSMETIC DERMATOLOGY OF RHODE ISLAND, LLC (billing NPI 1770770547) in the available physician profile data.

Does Marina Kuperman-Beade, M.D., F.A.A.D. have Open Payments data?

Marina Kuperman-Beade, M.D., F.A.A.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.